The 21st International Prostate Cancer Update
Wednesday, January 26, 2011 - Saturday, January 29, 2011

Cascade Conference Center
Vail, Colorado

Statement of Need

Prostate cancer is now the most common cancer outside of skin cancer. In 2009, an estimated 192,000 new cases of prostate cancer were diagnosed and about 27,000 men died from the disease.

Statement of Need

This case-based activity provides expert insight into controversies and unresolved issues experienced by practicing urologists who are clinically managing both prostate and bladder cancer. In both disease states, current therapy aims to eradicate the disease and to maintain patient quality of life. There are many options for localized therapy for prostate cancer; a significant percentage of these patients, however, will fail, with prostate-specific antigen (PSA) relapse, and the debate continues over optimum management of this patient population. In bladder cancer, new guidelines and therapies have further enhanced management options. The faculty provides an update on treatment guidelines, therapeutic options for localized bladder cancer, a review of current controversies, and pearls of management.